(Q33524952)

27 July 2017

1 reference

title

Functional imaging studies of non-motoric manifestations of Parkinson's Disease (English)

1 reference

27 July 2017

1 reference

A Jon Stoessl

1

0 references

publication date

1 December 2009

1 reference

Parkinsonism and Related Disorders

27 July 2017

published in

1 reference

27 July 2017

volume

15 Suppl 3

1 reference

27 July 2017

page(s)

S13-6

1 reference

Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970771-0

7 January 2021

Network modulation in the treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970771-0

7 January 2021

Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970771-0

7 January 2021

Metabolic brain networks associated with cognitive function in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970771-0

7 January 2021

Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970771-0

7 January 2021

The role of the striatum and hippocampus in planning: a PET activation study in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970771-0

7 January 2021

Striatal dopamine release during performance of executive functions: A [(11)C] raclopride PET study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970771-0

7 January 2021

Cognitive deficits and striato-frontal dopamine release in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970771-0

7 January 2021

Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970771-0

7 January 2021

Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970771-0

7 January 2021

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970771-0

7 January 2021

[11C]PIB binding in Parkinson's disease dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970771-0

7 January 2021

Imaging amyloid deposition in Lewy body diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970771-0

7 January 2021

Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970771-0

7 January 2021

Higher incidence of depression preceding the onset of Parkinson's disease: a register study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970771-0

7 January 2021

Increased risk of Parkinson's disease after depression: a retrospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970771-0

7 January 2021

Brain serotonin transporter binding in non-depressed patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970771-0

7 January 2021

Elevated serotonin transporter binding in depressed patients with Parkinson's disease: a preliminary PET study with [11C]DASB.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970771-0

7 January 2021

Spared caudal brainstem SERT binding in early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970771-0

7 January 2021

Staging of brain pathology related to sporadic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970771-0

7 January 2021

Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970771-0

7 January 2021

Personality traits and brain dopaminergic function in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970771-0

7 January 2021

Personality traits and striatal 6-[18F]fluoro-L-dopa uptake in healthy elderly subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970771-0

7 January 2021

Compulsive drug use linked to sensitized ventral striatal dopamine transmission

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970771-0

7 January 2021

Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970771-0

7 January 2021

Decreased striatal dopaminergic innervation in REM sleep behavior disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970771-0

7 January 2021

[18F]fluorodopa uptake in the upper brainstem measured with positron emission tomography correlates with decreased REM sleep duration in early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970771-0

7 January 2021

REM sleep behavior disorder is related to striatal monoaminergic deficit in MSA.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970771-0

7 January 2021

Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970771-0

7 January 2021

Orthostatic hypotension from sympathetic denervation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970771-0

7 January 2021

[N-methyl 11C]meta-Hydroxyephedrine positron emission tomography in Parkinson's disease and multiple system atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970771-0

7 January 2021

Amphetamine-induced increases in extracellular dopamine, drug wanting, and novelty seeking: a PET/[11C]raclopride study in healthy men.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970771-0

7 January 2021

Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970771-0

7 January 2021

Feeding-induced dopamine release in dorsal striatum correlates with meal pleasantness ratings in healthy human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970771-0

7 January 2021

Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970771-0

7 January 2021

Placebo mechanisms and reward circuitry: clues from Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970771-0

7 January 2021

Therapeutic application of transcranial magnetic stimulation in Parkinson's disease: the contribution of expectation

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970771-0

7 January 2021

Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970771-0

7 January 2021

Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970771-0

7 January 2021

10.1016/S1353-8020(09)70771-0

Identifiers

DOI

1 reference

27 July 2017

1 reference